Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis

Anal transitional zone dysplasia after stapled ileal pouch-anal anastomosis is infrequent, and usually self-limiting, finds a research team in the January issue of Diseases of the Colon and Rectum.

News image

fiogf49gjkf04

Stapling of the ileal pouch-anal anastomosis, with preservation of the anal transitional zone, remains controversial due to the potential risk of dysplasia and cancer.

However, natural history, and optimal treatment of anal transitional zone dysplasia, 10 or more years after surgery are unknown.

In this study, a research team from Cleveland, Ohio, established the risk of dysplasia in the anal transitional zone. They also assessed the outcome of a conservative management policy for anal transitional zone dysplasia, with a minimum of 10 years' follow-up after ileal pouch-anal anastomosis.

The team studied 289 patients undergoing anal transitional zone-sparing stapled ileal pouch-anal anastomosis for IBD, between 1986 and 1990.

They included 178 patients undergoing anal transitional zone-sparing ileal pouch-anal anastomosis, who were studied with serial anal transitional zone biopsies for at least 10 years, postoperatively.

Median follow-up was 130 months.

No cancer was found in the anal transitional zone during the study period.
Diseases of the Colon and Rectum

The researchers found that anal transitional zone dysplasia developed in 8 patients, between 4 and 123 months after surgery.

The team identified no association with gender, age, preoperative disease duration, or extent of colitis. However, the risk of anal transitional zone dysplasia was associated with cancer or dysplasia as a preoperative diagnosis, or in the proctocolectomy specimen.

Dysplasia was high grade in 2 patients and low grade in 6.

Of these, 2 patients with low-grade dysplasia, on 2 or more occasions after detection of low-grade dysplasia, underwent completion mucosectomy and perineal pouch advancement with neo-ileal pouch-anal anastomosis.

Of the patients with high-grade dysplasia, 1 was to undergo completion mucosectomy, however this was not found to be technically feasible. Instead, partial mucosectomy, with vigorous anal transitional zone biopsy, was performed with close postoperative surveillance. Biopsies were negative for dysplasia.

The second high-grade dysplasia underwent examination under anesthesia with negative anal transitional zone biopsies and will be kept under close surveillance.

The team found no cancer in the anal transitional zone during the study period.

The research team treated the 4 other patients with low-grade dysplasia expectantly, and have been dysplasia-free for a median of 119 months.

Dr Feza Remzi’s team concluded, “Anal transitional zone dysplasia after stapled ileal pouch-anal anastomosis is infrequent and is usually self-limiting”.

“Anal transitional zone preservation did not lead to the development of cancer in the anal transitional zone with a minimum of 10 years of follow-up.”

“Long-term surveillance is recommended to monitor dysplasia.”

“If repeat biopsy confirms persistent dysplasia, mucosectomy with perineal pouch advancement and neo-ileal pouch-anal anastomosis is recommended.”

Dis Colon Rectum 2003; 46(1): 6-13
22 January 2003

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us